CATX — Perspective Therapeutics Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates CATX Bearish with a Setup Score of 36, net conviction 55, actionability 24. How the Setup Score works →

Total Setup Score36
Directional BiasBearish
Net Conviction55
Actionability24 (in range)

Key signals behind this score

About Perspective Therapeutics Inc.

Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted r… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$3.19
Market Cap$397M
Float67.9M
Shares Outstanding114.2M
P/E (Forward)25.71
Price/Sales (TTM)895.91
vs. Analyst Target+296.3% to analyst PT
Operating Margin (TTM)-36120.99%
Revenue (TTM)$409,000
Dividend RateNone
Analyst Target Price$12.64 (14 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2022 $10.8M -$7.2M $4.6M -$7.1M
2022 $7.1M -$14.7M $1.6M -$14.8M
2023 $7.1M -$14.7M $1.6M -$14.8M
2023 $1.4M -$46.5M $1.4M -$40.0M
2024 $1.5M -$79.3M -$852,000 $10.5M
2025 $884,000 -$103M -$2.4M -$101M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 $209,000 -$26.0M
Dec 2025 $43,000 -$37.5M
Mar 2026 $76,000 -$26.2M
Jun 2026 $81,000 -$26.8M

Ownership & Float

Insider Ownership10.8%
Institutional Ownership85.9%
Short Float34.6%
% of All Funds Holding1.46%
Number of Funds Holding128

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$3.12Near-term / short-term trend
Weekly40-Week SMA$3.59Medium-term trend
Weekly80-Week SMA$3.32Cyclical trend (business cycle)
Weekly200-Week SMA$5.63Secular trend (multi-year)
Monthly10-Month SMA$3.58Near-term monthly trend
Monthly20-Month SMA$3.30Medium-term monthly trend
Monthly40-Month SMA$5.79Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$2.80 support 3.25x 6 months ago
$11.90 resistance 2.64x 20 months ago

Historical Earnings Reactions (78 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.18% 0.00% 39.74% 21.79% -28.57%
1 Day -1.62% -0.70% 37.18% 25.00% -26.67%
1 Week -0.50% -2.70% 41.03% 109.52% -42.17%
2 Weeks 0.79% -5.45% 38.96% 107.14% -61.39%
1 Month 3.59% -2.38% 42.86% 250.72% -67.39%

Next earnings: October 29, 2026 (64 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan29.2%61.9%21
Feb-3.4%33.3%21
Mar7.4%42.9%21
Apr9.6%57.1%21
May1.9%42.9%21
Jun-2.5%33.3%21
Jul6.0%42.9%21
Aug5.2%35.0%20
Sep-9.6%25.0%20
Oct-7.3%25.0%20
Nov-1.9%30.0%20
Dec-3.5%38.1%21

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.11% 34.0% 979
Tuesday -0.12% 35.8% 1073
Wednesday 0.88% 40.0% 1073
Thursday 0.01% 39.5% 1052
Friday 0.30% 39.5% 1048

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 85.9%

Insider Transactions — Smart Summary

Total insider ownership: 10.8%

12-Month Insider Activity Summary

Total Filings2
Net Value+$22,294.8
Net Shares Change20,498
% of Float0.0%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Hunt Jonathan Robert Chief Accounting Officer +$22,294.8 1 1 buy
Williamson Robert F III +$19,945.8 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-11-17 Hunt Jonathan Robert Chief Accounting Officer +$22,294.8 Transaction at $2.03, now +57.4%
2025-11-14 Williamson Robert F III +$19,945.8 Transaction at $2.10, now +51.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Perspective Therapeutics Inc. (CATX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CATX on Trend Edge →